Hostname: page-component-745bb68f8f-g4j75 Total loading time: 0 Render date: 2025-02-03T09:02:48.006Z Has data issue: false hasContentIssue false
  • English
  • Français

[Dr. Rhine responds:]

Published online by Cambridge University Press:  21 May 2015

D.J. Rhine
D.J. Rhine*
Affiliation:
Department of Emergency Medicine, King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters • Courrier
Information
Canadian Journal of Emergency Medicine , Volume 3 , Issue 1 , January 2001 , pp. 5 - 6
Copyright
Copyright © Canadian Association of Emergency Physicians 2001

References

1.Gubitz, G, Phillips, S.Intravenous tPA for acute stroke [letter]. CJEM 2001;3(1):5.CrossRefGoogle Scholar
2.Rhine, D.Intravenous tPA for acute stroke: Any and all hospitals? Any and all strokes? CJEM 2000;2(3):189–91.CrossRefGoogle Scholar
3.Canadian Association of Emergency Physicians Committee on Thrombolytic Therapy for Actue Ischemic Stroke. Thrombolytic therapy for acute ischemic stroke [position statement]. CJEM 2001; 3(1):8–12.CrossRefGoogle Scholar
4.Kay, R, Wong, KS, Yu, YL, Chan, YW, Tsoi, TH, Ahuja, AT, et al. Low-molecular-weight heparin for the treatment of acute ischemic stroke. N Engl J Med 1995;333:1588–93.CrossRefGoogle ScholarPubMed
5.Counsell, C, Sandercock, P.Low-molecular-weight heparins or heparinoids versus standard unfractionated heparin for acute ischaemic stroke. Cochrane Database of Systematic Reviews 2000;2:CD000119.Google Scholar